Floatz logo

Gm-Csf

Acute Lymphoblastic Leukemia

Xinhua Hospital, Shanghai Jiao Tong University School of MedicineUNKNOWNPhase 4 / ApprovedDormant
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

247 Active assets in the Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
Peripheral Blood Stem Cells, Allogeneic, Cd34 Positive
Fred Hutchinson Cancer Center
Phase 2/3BBB
Equine Atg
Instituto Nacional de Cancer, Brazil
Phase 3BBB
THIOGUANINE ANHYDROUS
St. Jude Children's Research Hospital
Phase 4BBB
Cyclophosphamide
Sawa Ito, MD
Phase 4BB
MERCAPTOPURINE ANHYDROUS
Dana-Farber Cancer Institute
Phase 4BB

View all 50 →

Same molecule, other indications

Gm-Csf is also rated in:

melanomaDormant
BBB
Indicative · Phase 4
74 / 100
View asset →
uveal melanomaDormant
BB
Indicative · Phase 2
69 / 100
View asset →
cutaneous melanomaDormant
BB
Indicative · Phase 2
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →